Ypsomed Holding AG (CHIX:YPSNz)
CHF 386.5 1 (0.26%) Market Cap: 5.25 Bil Enterprise Value: 5.43 Bil PE Ratio: 67.25 PB Ratio: 8.53 GF Score: 80/100

Full Year 2023 Ypsomed Holding AG Earnings Call Transcript

May 24, 2023 / 01:30PM GMT
Simon Michel
Ypsomed Holding AG - CEO & Member of the Board

Dear shareholders and partners, at Ypsomed, we can look back on another successful year.

In Delivery Systems, we achieved a record result with our pens and autoinjectors. In pens, we are proud to be making an important contribution to access to affordable insulin with several significant collaborations in this space. In autoinjectors, the YpsoMate 2.25 for large volumes, in particular, achieved very strong sales growth. And based on our partnerships with Abbott, Dexcom and CamDiab, we are finally achieving satisfying results in our Diabetes Care business as well.

We were able to more than double commercial sales of our YpsoPump business last year. And we are excited to significantly improve life for people with diabetes with our mylife Loop AID solution that enables users to benefit from a unique and adaptive algorithm that runs on smartphones.

We exceeded the interim target of 30,000 active pump users at the end of the financial year and see a clear path towards profitability in our pump business.

So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot